Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy.
<h4>Background</h4>Dysferlinopathies are caused by mutations in the dysferlin gene (DYSF). Diagnosis is complex due to the high clinical variability of the disease and because dysferlin expression in the muscle biopsy may be secondarily reduced due to a primary defect in some other gene....
Main Authors: | Eduard Gallardo, Noemi de Luna, Jordi Diaz-Manera, Ricardo Rojas-García, Lidia Gonzalez-Quereda, Bàrbara Flix, Antoine de Morrée, Silvère van der Maarel, Isabel Illa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22194990/?tool=EBI |
Similar Items
-
Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes
by: Esther Fernández-Simón, et al.
Published: (2020-11-01) -
Dysferlin-peptides reallocate mutated dysferlin thereby restoring function.
by: Verena Schoewel, et al.
Published: (2012-01-01) -
Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity.
by: Antoine de Morrée, et al.
Published: (2010-01-01) -
Minimal expression of dysferlin prevents development of dysferlinopathy in dysferlin exon 40a knockout mice
by: Joe Yasa, et al.
Published: (2023-01-01) -
Full-length Dysferlin Transfer by the Hyperactive Sleeping Beauty Transposase Restores Dysferlin-deficient Muscle
by: Helena Escobar, et al.
Published: (2016-01-01)